Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Vertex Ada Poster

<< Previous

Bullboard Posts

Next >>

Comment by BioTeckon May 31, 2022 11:57am

125 Views

Post# 34720267

RE:Vertex Ada Poster

We should all start posting on twitter using the #ADA2022 hashtag. If PR won't do anything, might have to take marketing into our own hands. Just need a few message templates that tell the story well with a couple good links and go around posting messages in Diabetes forums and social media, Reddit.

Sally, yes the folks reported on don't seem to be too sick. Maybe Spill will ask the question at the conference.

MustangSalley wrote:
If you look at their poster Hba1c baseline levels for a severe hypoglycaemic are 8.6 and only reduced by one point . Whereas Sva patients had numbers go from 11 to 6 .

Vertex does not have really sick patients in their trial. Question is Why Fda halt their trial?

https://eppro02.ativ.me/src/EventPilot/php/express/web/planner.php?id=ADA22

MS